GlobeNewswire 上市公司公告·· 2 小时前AI 评分15
Quoin Pharmaceuticals 宣布 QRX003 论文获《Dermatology and Therapy》接收
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
AI 导读
Quoin Pharmaceuticals（NASDAQ: QNRX）宣布，题为“An Investigational Mechanism-Informed Therapy for Netherton Syndrome。
来源：GlobeNewswire 上市公司公告 · globenewswire.com